Holen Sie sich die Stockscreener-App
39.07
0.24%
-0.13
Schlusskurs vom Vortag:
$39.20
Offen:
$39.34
24-Stunden-Volumen:
5.70M
Relative Volume:
0.21
Marktkapitalisierung:
$8.91B
Einnahmen:
$1.78B
Nettoeinkommen (Verlust:
$164.40M
KGV:
56.62
EPS:
0.69
Netto-Cashflow:
$236.51M
1W Leistung:
+4.25%
1M Leistung:
-4.69%
6M Leistung:
-30.58%
1J Leistung:
+14.24%
1-Tages-Spanne:
$38.24
$39.60
1-Wochen-Bereich:
$35.78
$40.99
52-Wochen-Spanne:
$23.97
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Firmenname
Hims Hers Health Inc
Sektor
Telefon
415-851-0195
Adresse
2269 CHESTNUT ST, SAN FRANCISCO
Vergleichen Sie HIMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
39.13 | 8.92B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
119.13 | 52.29B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.21 | 44.80B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.405 | 42.39B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.45 | 32.65B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
476.56 | 21.07B | 3.08B | 1.24B | 1.07B | 25.61 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | Herabstufung | Needham | Buy → Hold |
| 2025-06-04 | Bestätigt | Needham | Buy |
| 2025-04-29 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-01-07 | Eingeleitet | BTIG Research | Buy |
| 2024-12-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-08-22 | Eingeleitet | Needham | Buy |
| 2024-08-09 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-04-16 | Herabstufung | Jefferies | Buy → Hold |
| 2024-04-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-02-28 | Hochstufung | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | Imperial Capital | In-line |
| 2023-07-28 | Eingeleitet | TD Cowen | Outperform |
| 2023-04-11 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-02-09 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-08 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-07-15 | Eingeleitet | SVB Leerink | Underperform |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-10 | Eingeleitet | Deutsche Bank | Hold |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-11-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Eingeleitet | BofA Securities | Neutral |
| 2021-05-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Eingeleitet | Truist | Hold |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-03-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Eingeleitet | Citigroup | Neutral |
| 2021-02-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-02-08 | Eingeleitet | Tigress Financial | Buy |
Alle ansehen
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Pharma company eyes Canada as patents lapse on weight-loss drugs - Benefits and Pensions Monitor
Truist Securities reiterates Hold rating on Hims and Hers stock amid soft Q4 trends - Investing.com UK
Divisadero Street Capital Management LP Sells 646,934 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Why Hims & Hers Stock Slipped Today - AOL.com
Promising Healthcare Stocks To Add to Your WatchlistDecember 7th - MarketBeat
Hims & Hers Health Stock (HIMS) Opinions on Q3 Earnings and Telehealth Trends - Quiver Quantitative
Jump Financial LLC Sells 155,479 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers: The Market's Panic Is Irrational (NYSE:HIMS) - Seeking Alpha
Arrowstreet Capital Limited Partnership Has $28.36 Million Holdings in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health, Inc. $HIMS Stake Lowered by State Board of Administration of Florida Retirement System - MarketBeat
Clear Street LLC Invests $83.58 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
HIMS CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Remin - The National Law Review
HIMS HERS HEALTH INC - Financial Post
Hims and Hers acquires Livewell ahead of generic Ozempic launch in Canada - Financial Post
Tempus AI Boosts Its Clinical AI Capabilities Through Strategic Moves - TradingView
Hims & Hers Continues Major International Expansion With Officia - GuruFocus
Leerink Partnrs Upgrades Hims & Hers Health (NYSE:HIMS) to Strong-Buy - MarketBeat
2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm - Finviz
Norges Bank Makes New $78.46 Million Investment in Hims & Hers Health, Inc. $HIMS - MarketBeat
A New Market, A New Catalyst: Assessing Hims & Hers' Canadian Opportunity (NYSE:HIMS) - Seeking Alpha
American Century Companies Inc. Buys 42,510 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Notable Thursday Option Activity: HIMS, GAP, BE - Nasdaq
Hims & Hers Health, Inc. acquired Livewell. - marketscreener.com
Hims & Hers Snaps Up YourBio To Bring Pain-Free Blood Tests Home - Sahm
Hims & Hers propose désormais ses services aux clients du Canada - Hastings Tribune
Hims & Hers expands into diagnostics, moves into Canada as it evolves DTC telehealth platform - Fierce Healthcare
HIMS Stock Jumps After Buyout Deal, Boosts Blood Collection Efficiency - Nasdaq
Hims & Hers Targets Canadian Obesity Crisis in Bold Weight-Loss Push with Semaglutide Tailwind - Yahoo Finance
What's Going On With Shares Of Hims & Hers Health Thursday? - Benzinga
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Finviz
Leerink Partners lowers Hims and Hers stock price target on increased investment costs By Investing.com - Investing.com
Market movers: Meta, Hims and Hers, Dollar General, Gunnison Copper… - Proactive financial news
Hims & Hers Health (HIMS) Expands into Canada with Livewell Acqu - GuruFocus
Hims & Hers Health stock rises after Canadian market entry By Investing.com - Investing.com UK
Schroder Investment Management Group Has $20.57 Million Holdings in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health Acquires Livewell, Officially Enters Canadian Market - marketscreener.com
Hims & Hers expands into Canadian market following Livewell acquisition - Investing.com India
Hims & Hers shares jump on expansion into Canada - Proactive financial news
Hims & Hers expands into Canadian market following Livewell acquisition By Investing.com - Investing.com UK
Hims & Hers Now Serving Customers in Canada - Hims Investor Relations
Hims & Hers Continues Major International Expansion With Official Entry Into Canada - The Joplin Globe
Hims & Hers Continues Major International Expansion with Official Entry into Canada - Hims & Hers Newsroom
Hims & Hers acquires Livewell in Canada in anticipation of generic Ozempic - The Globe and Mail
What Hims & Hers Health (HIMS)'s Margin Squeeze, Buyback and YourBio Deal Mean For Shareholders - Yahoo Finance
Hims & Hers Health signs agreement to acquire YourBio Health - Yahoo Finance
Hims & Hers Stock Gains on Move Into Canada - The Wall Street Journal
Hims & Hers to acquire blood sampling tech company - Modern Healthcare
Hims & Hers Health (HIMS) Down 15.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Hims & Hers Expands Care Scope as Prescription Platforms Evolve - Yahoo Finance
Hims & Hers to acquire YourBio Health, pioneer behind advanced, pain-free blood sampling technology - marketscreener.com
Hims & Hers Health (HIMS) to Acquire YourBio Health for Tech Exp - GuruFocus
Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):